In other countries
The same active substances on other registers, the same brand first.
- EydenzeltBrazil · Celltrion Healthcare Distribuicao de Produtos Farmaceuticos Dos Brasil LtdaSame brand
- EydenzeltCanada · 2 MG / 0.05 ML · Solution · Celltrion INC.Same brand
- EydenzeltCanada · 2 MG / 0.05 ML · Solution · Celltrion INC.Same brand
- Eydenzelt 40 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 2 mg · solución inyectable en jeringa precargada · Celltrion Healthcare Hungary Kft.Same brand
- Eydenzelt 40 MG/ML Solucion Inyectable en VialSpain · 2 mg · solución inyectable · Celltrion Healthcare Hungary Kft.Same brand
- EydenzeltEuropean Union · Celltrion Healthcare Hungary Kft.Same brand
- EydenzeltCroatiaSame brand
- EydenzeltItaly · Soluzione iniettabile · Celltrion Healthcare Hungary KFTSame brand
- Eydenzelt 40 mg/ml oplossing voor injectie in een injectieflaconNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.Same brand
- Eydenzelt 40 mg/ml oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.Same brand
- Afqlir 40 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 40 mg/ml · solución inyectable en jeringa precargada · Sandoz GmbhSame form
- AfqlirItaly · Soluzione iniettabile · Sandoz GMBHSame form
- AhzantiveItaly · Soluzione iniettabile · Formycon AGSame form
- Afiveg 40 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Stada Arzneimittel AGSame form
- EyleaNew Zealand · Inj 40 mg per ml, 0.1 ml vialSame form
- EYLEA 40mg/mlRomania · 40mg/ml · sol. inj. · Bayer Pharma AGSame form
- EYLEA 40mg/mlRomania · 40mg/ml · sol inj. · Bayer AGSame form
- Eylea®Serbia · 40mg/mL · rastvor za injekciju · Bayer D.O.O. BeogradSame form
- Eylea®Serbia · 114.3mg/mL · rastvor za injekciju · Bayer D.O.O. BeogradSame form
- Eylea®Serbia · 40mg/mL · rastvor za injekciju · Bayer D.O.O. BeogradSame form
- EYLEA 40 mg/ml solution for injectionSaudi Arabia · Bayer AGSame form
- Eylea 40 mg/ml Solution for injection in pre-filled syringeSaudi Arabia · Bayer AGSame form
- EYLEA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 40 mg/mlSingapore · 2.0mg/50mcl · injection, solution · Bayer (South East Asia) Pte LTDSame form
- Eylea Solution for Injection in Vial 2MGSingapore · 2.0mg/50mcl · injection, solution · Bayer (South East Asia) Pte LTDSame form
- Eylea Solution for Injection in Vial 8MGSingapore · 114.3mg/ml · injection, solution · Bayer (South East Asia) Pte LTDSame form
- EyliaBrazil · Bayer S.A.Same substance
- PavbluBrazil · Amgen Biotecnologia do Brasil Ltda.Same substance
- AflivuCanada · 2 MG / 0.05 ML · Solution · Apotex INCSame substance
- AfivegEuropean Union · STADA Arzneimittel AGSame substance
- AfqlirEuropean Union · Sandoz GmbHSame substance
- AfqlirCroatiaSame substance
- EyleaCroatiaSame substance
- ZALTRAP 25 mg/mlRomania · 25mg/ ml · conc. pt. sol. perf. · Sanofi - Aventis GroupeSame substance
- EYLEA 114.3 mg/ml solution for injectionTaiwan · 注射液劑 · 台灣拜耳股份有限公司Same substance
- Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection vialTaiwan · 注射劑 · 台灣拜耳股份有限公司Same substance
- Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringeTaiwan · 注射劑 · 台灣拜耳股份有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
U.S. Food and Drug Administration
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Aflibercept
- Strength
- 2MG/0.05ML
- Dosage form
- Injection
- Route
- Intravitreal
- Register
- United States (FDA)
- Status
- Marketed
- Status in the register
- Licensed / Rx
- Authorised
- 2 Oct 2025
- Registration
- BLA 761377
- Marketing authorisation holder
- CELLTRION, Inc.
- Procedure
- 351(k) Biosimilar
- Supply
- Rx